Article

Hyperglycemia in Hospitalized Patients

Nicole Artz, MD, a hospitalist and Assistant Professor of Medicine at the University of Chicago Hospital, discusses implications of hyperglycemia in hospitalized patients.

Nicole Artz, MD, a hospitalist and Assistant Professor of Medicine at the University of Chicago Hospital, discusses implications of hyperglycemia in hospitalized patients.

Related Videos
Advocating for Race-Neutral Approach to Pulmonary Function Testing with Meredith McCormack, MD, and Loretta Que, MD
Gregory Mattingly, MD I St. Charles Psychiatric Associates
Duloxetine for Patients with COPD Suffering from Comorbid Depression
Enhancing Standards for Ethical Responsibilities within Clinical Research
Jennifer Flemming, MD | Credit: AASLD
Related Content
FDA black and white logo | Credit: US Food and Drug Administration
January 28th 2025

FDA Approves Semaglutide (Ozempic) for Type 2 Diabetes, Chronic Kidney Disease

Abigail Brooks, MA
Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes Therapeutics| Image Credit: HCPLive
January 23rd 2025

Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes Therapeutics

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
Thyroid Cancer Diagnoses Rise in First Year of GLP-1 RA Use | Image Credit: University of Maryland
January 24th 2025

Thyroid Cancer Diagnoses Rise in First Year of GLP-1 RA Use

Connor Iapoce
Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes | Image Credit: HCPLive
January 16th 2025

Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes Technology

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
Patient Factors Influence Semaglutide Initiation After Obesity Diagnosis | Image Credit: Boston University
January 21st 2025

Patient Factors Influence Semaglutide Initiation After Obesity Diagnosis

Connor Iapoce
Semaglutide 7.2 mg Exhibits 20.7% Weight Loss in Phase 3b STEP UP Trial | Image Credit: Novo Nordisk
January 17th 2025

Semaglutide 7.2 mg Displays 20.7% Weight Loss in Phase 3b STEP UP Trial

Connor Iapoce
© 2025 MJH Life Sciences

All rights reserved.